Investing.com -- LENZ Therapeutics (NASDAQ:LENZ) stock tumbled 25% on heavy volume Friday in New York after a case of retinal tear associated with its VIZZ eye drop appeared in the FDA’s adverse event ...
TipRanks on MSN
Lenz drops nearly 30% after FDA’s FAERS finds retinal tear
Shares of Lenz Therapeutics (LENZ) dropped after a case of retinal tear surfaced inn the FDA’s adverse-event database known as FAERS. The company, ...
LENZ Therapeutics (LENZ) stock drops as an FDA database indicates an adverse event linked to the company's newly launched eye ...
LENZ Therapeutics (LENZ) is aware of a recent adverse event report submitted to the U.S. Food and Drug Administration’s Adverse Event Reporting System database describing a retinal tear in a patient ...
Particulate Matter – Microscopic particles from sources like construction, automobile exhaust, and industrial emissions cause ...
News Medical on MSN
Genetic differences in surfactant proteins influence retinopathy of prematurity risk
A new study from the University of Oklahoma suggests that small genetic differences in two proteins – previously known for their role in premature infants' lungs – may also influence how their eyes ...
Asda Opticians launched its first ever training scheme in September to enable university graduates to become GOC-registered optometrists. Emma Spencer reports ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback